StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
RBC Affirms Valeant (VRX) at 'Sector Perform'; Q2 Slightly Below Views, Walgreens Derm co-Pay Shows Improvement
August 9, 2016 9:32 AM
RBC affirms Valeant (NYSE: VRX) Sector Perform with a price target of $31 following Q2 results on Tuesday.Analyst Douglas Miehm ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Next Articles
Valeant (VRX) PT Bumped to $22 at Piper Jaffray; Keeps Lowest Rating
August 10, 2016 7:04 AM
Nasdaq hits record high, other indexes hover near highs
August 9, 2016 7:31 AM
Valeant (VRX) August weekly volatility elevated as shares up in premarket on Q2 and outlook
August 9, 2016 6:20 AM
Form 8-K Valeant Pharmaceuticals For: Aug 09
August 9, 2016 6:10 AM
Valeant Pharma (VRX) Misses Q2 EPS by 8c, Reaffirms Guidance; Will Divest Ruconest Rights in N.A.
August 9, 2016 6:01 AM
